Page last updated: 2024-08-26

brexanolone and Pregnancy

brexanolone has been researched along with Pregnancy in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (33.33)24.3611
2020's8 (66.67)2.80

Authors

AuthorsStudies
Battle, CL; Diaz, Z; Howard, MM1
Leader, LD; O'Connell, M; VandenBerg, A1
Barron, RJ; Jarman, AF; MacLean, JV; McGregor, AJ; Wightman, RS1
Cieri-Hutcherson, NE; Gosciak, MF; Hutcherson, TC1
Bond, JC; Chertavian, E; Cohen, JT; Eldar-Lissai, A; Gerbasi, ME; Hodgkins, P; Johnson, SJ; Meltzer-Brody, S1
Kroska, EB; Stowe, ZN1
Nguyen, DR; Patatanian, E1
Payne, JL1
Cooke, E; Leader, LD; VandenBerg, A; Walkery, A1
Clemson, C; Colquhoun, H; Deligiannidis, KM; Epperson, CN; Jonas, J; Kanes, S; Li, H; Meltzer-Brody, S; Riesenberg, R; Rubinow, DR; Sankoh, AJ; Schacterle, A1
Mody, I1

Reviews

5 review(s) available for brexanolone and Pregnancy

ArticleYear
Brexanolone for Postpartum Depression: Clinical Evidence and Practical Considerations.
    Pharmacotherapy, 2019, Volume: 39, Issue:11

    Topics: Antidepressive Agents; beta-Cyclodextrins; Depression, Postpartum; Drug Combinations; Female; GABA Modulators; Humans; Pregnancy; Pregnanolone; Psychiatric Status Rating Scales; Severity of Illness Index

2019
Brexanolone for postpartum depression.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2020, Feb-19, Volume: 77, Issue:5

    Topics: Antidepressive Agents; beta-Cyclodextrins; Depression, Postpartum; Drug Combinations; Female; Humans; Pregnancy; Pregnanolone; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Risk Evaluation and Mitigation; Severity of Illness Index

2020
Postpartum Depression: Identification and Treatment in the Clinic Setting.
    Obstetrics and gynecology clinics of North America, 2020, Volume: 47, Issue:3

    Topics: Adult; Antidepressive Agents; beta-Cyclodextrins; Depression, Postpartum; Drug Combinations; Female; Humans; Infant; Mass Screening; Neurosteroids; Perinatal Care; Postpartum Period; Pregnancy; Pregnanolone; Prevalence; Psychiatric Status Rating Scales; Psychotherapy; Risk Factors; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires

2020
Brexanolone: A Novel Drug for the Treatment of Postpartum Depression.
    Journal of pharmacy practice, 2022, Volume: 35, Issue:3

    Topics: beta-Cyclodextrins; Depression, Postpartum; Drug Combinations; Female; Humans; Pregnancy; Pregnanolone; Unconsciousness

2022
Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders.
    Drug design, development and therapy, 2021, Volume: 15

    Topics: Antidepressive Agents; beta-Cyclodextrins; Bipolar Disorder; Depression, Postpartum; Depressive Disorder; Drug Combinations; Female; Humans; Pregnancy; Pregnanes; Pregnanolone; Psychiatric Status Rating Scales; Pyrazoles

2021

Trials

1 trial(s) available for brexanolone and Pregnancy

ArticleYear
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.
    Lancet (London, England), 2018, 09-22, Volume: 392, Issue:10152

    Topics: Adult; beta-Cyclodextrins; Depression, Postpartum; Double-Blind Method; Drug Combinations; Female; GABA Agonists; Humans; Injections, Intravenous; Pregnancy; Pregnancy Trimester, Third; Pregnanolone; Psychiatric Status Rating Scales; Receptors, GABA; Severity of Illness Index; Treatment Outcome; Young Adult

2018

Other Studies

6 other study(ies) available for brexanolone and Pregnancy

ArticleYear
Implementation of a Hospital-based Brexanolone Program.
    Journal of psychiatric practice, 2022, 09-01, Volume: 28, Issue:5

    Topics: beta-Cyclodextrins; Depression, Postpartum; Drug Combinations; Female; Hospitals; Humans; Pregnancy; Pregnanolone

2022
Brexanolone For Postpartum Depression: A Novel Approach and a Call for Comprehensive Postpartum Care.
    Clinical therapeutics, 2020, Volume: 42, Issue:1

    Topics: Antidepressive Agents; beta-Cyclodextrins; Depression, Postpartum; Drug Combinations; Female; Humans; Neurosteroids; Postpartum Period; Pregnancy; Pregnanolone

2020
Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United States.
    Journal of managed care & specialty pharmacy, 2020, Volume: 26, Issue:5

    Topics: Adolescent; Adult; beta-Cyclodextrins; Cost-Benefit Analysis; Depression, Postpartum; Drug Combinations; Female; Humans; Pregnancy; Pregnanolone; Prenatal Care; Psychometrics; Quality-Adjusted Life Years; Selective Serotonin Reuptake Inhibitors; United States; Young Adult

2020
Evaluating brexanolone for the treatment of postpartum depression.
    Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:8

    Topics: beta-Cyclodextrins; Child; Depression, Postpartum; Drug Combinations; Female; Humans; Pregnancy; Pregnanolone

2021
GABA
    Cell, 2019, 01-10, Volume: 176, Issue:1-2

    Topics: Adult; beta-Cyclodextrins; Depression, Postpartum; Depressive Disorder, Major; Drug Combinations; Female; Humans; Mood Disorders; Neurotransmitter Agents; Postpartum Period; Pregnancy; Pregnanolone; Prevalence; Receptors, GABA-A

2019
Brexanolone (Zulresso) for postpartum depression.
    The Medical letter on drugs and therapeutics, 2019, May-06, Volume: 61, Issue:1571

    Topics: beta-Cyclodextrins; Depression, Postpartum; Drug Combinations; Female; Humans; Pregnancy; Pregnanolone; Receptors, GABA-A

2019